About Invivyd
Vaccines can only take us so far. Antibodies are the natural next step.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- New Haven, Connecticut
- Founded
- 2020
- Company type
- Public Company
Invivyd, Inc. (Nasdaq: IVVD) creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, drug and adapt to create best in class antibodies.
Company locations
209 Church St, New Haven, Connecticut 06510, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Biotechnology
- Pharmaceutical
- Therapeutics
On LinkedIn
- Followers
- 18,479
- People linked to this company
- 177
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
678,500,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.